David A. York

11.3k total citations · 3 hit papers
190 papers, 9.2k citations indexed

About

David A. York is a scholar working on Physiology, Endocrine and Autonomic Systems and Nutrition and Dietetics. According to data from OpenAlex, David A. York has authored 190 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Physiology, 92 papers in Endocrine and Autonomic Systems and 50 papers in Nutrition and Dietetics. Recurrent topics in David A. York's work include Regulation of Appetite and Obesity (90 papers), Adipose Tissue and Metabolism (81 papers) and Diet and metabolism studies (41 papers). David A. York is often cited by papers focused on Regulation of Appetite and Obesity (90 papers), Adipose Tissue and Metabolism (81 papers) and Diet and metabolism studies (41 papers). David A. York collaborates with scholars based in United States, United Kingdom and Russia. David A. York's co-authors include George A. Bray, Shuichi Okada, Michael Lefevre, Daniel Hwang, Brenda Smith, V. Godbole, Lih‐Yuan Lin, S. J. Holt, Michael J. Quon and Zhan‐Guo Gao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

David A. York

189 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis.

1979 967 citations George A. Bray, David A. York profile →
Neurobiology of Exercise

2006 690 citations David A. York et al. Obesity profile →
Serine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor κB Kinase Complex

2002 589 citations David A. York et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. York United States	49	4.4k	3.8k	2.0k	1.6k	1.2k	190	9.2k
Charles V. Mobbs United States	44	3.0k 0.7×	3.7k 1.0×	1.7k 0.9×	1.7k 1.1×	1.1k 0.9×	146	8.4k
Barry E. Levin United States	63	6.0k 1.3×	7.5k 2.0×	2.5k 1.3×	1.8k 1.2×	1.3k 1.1×	232	13.8k
Akio Inui Japan	56	5.1k 1.2×	5.9k 1.6×	3.3k 1.7×	1.9k 1.2×	1.2k 1.0×	312	11.9k
Akira Niijima Japan	50	3.4k 0.8×	4.3k 1.1×	2.1k 1.1×	849 0.5×	504 0.4×	171	8.3k
Françoise Rohner‐Jeanrenaud Switzerland	47	2.7k 0.6×	3.0k 0.8×	1.4k 0.7×	982 0.6×	1.4k 1.2×	97	6.2k
Margaret J. Morris Australia	59	4.0k 0.9×	2.7k 0.7×	1.4k 0.7×	3.2k 2.0×	905 0.8×	378	13.9k
Nori Geary United States	46	2.5k 0.6×	4.0k 1.0×	1.8k 0.9×	918 0.6×	616 0.5×	167	7.7k
Amanda Sainsbury Australia	59	4.3k 1.0×	3.5k 0.9×	1.1k 0.6×	1.7k 1.1×	1.1k 1.0×	201	10.4k
Christopher D. Morrison United States	52	3.8k 0.9×	3.9k 1.0×	1.8k 0.9×	2.0k 1.3×	1.3k 1.1×	153	9.4k
Timothy H. Moran United States	64	4.6k 1.0×	5.7k 1.5×	2.9k 1.5×	3.6k 2.3×	1.1k 1.0×	323	15.8k

Countries citing papers authored by David A. York

Since Specialization

Citations

This map shows the geographic impact of David A. York's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. York with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. York more than expected).

Fields of papers citing papers by David A. York

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. York. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. York. The network helps show where David A. York may publish in the future.

Co-authorship network of co-authors of David A. York

This figure shows the co-authorship network connecting the top 25 collaborators of David A. York. A scholar is included among the top collaborators of David A. York based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. York. David A. York is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

York, David A., et al.. (2010). Effects of dietary fat and enterostatin on dopamine and 5-hydroxytrytamine release from rat striatal slices. Brain Research. 1349. 48–55. 12 indexed citations

York, David A., et al.. (2010). Melanocortin activity in the amygdala influences alcohol intake. Pharmacology Biochemistry and Behavior. 98(1). 112–119. 8 indexed citations

Park, MieJung, et al.. (2008). Enterostatin affects cyclic AMP and ERK signaling pathways to regulate Agouti-related Protein (AgRP) expression. Peptides. 30(2). 181–190. 14 indexed citations

Gordaninejad, Faramarz, Olivia A. Graeve, Alan Fuchs, & David A. York. (2007). Proceedings of the 10th International Conference on Electrorheological Fluids and Magnetorheological Suspensions : Lake Tahoe, USA, June 18-22, 2006. WORLD SCIENTIFIC eBooks. 2 indexed citations

White, Christy L., Yuri Ishihara, David A. York, & George A. Bray. (2007). Effect of Meta‐chlorophenylpiperazine and Cholecystokinin on Food Intake of Osborne‐Mendel and S5B/P1 Rats. Obesity. 15(3). 624–631. 11 indexed citations

White, Christy L., Yasuyuki Ishii, N. Upton, et al.. (2005). Effect of a selective OX1R antagonist on food intake and body weight in two strains of rats that differ in susceptibility to dietary-induced obesity. Peptides. 26(11). 2331–2338. 43 indexed citations

Lin, Ling & David A. York. (2005). 5-HT1B receptors modulate the feeding inhibitory effects of enterostatin. Brain Research. 1062(1-2). 26–31. 15 indexed citations

York, David A., Stephan Rössner, Ian D. Caterson, et al.. (2004). Obesity, a worldwide epidemic related to heart disease and stroke: Group I: Worldwide demographics of obesity. Circulation. 110(18). 463–470. 18 indexed citations

York, David A.. (1999). Peripheral and Central Mechanisms Regulating Food Intake and Macronutrient Selection. Obesity Surgery. 9(5). 471–479. 27 indexed citations

10.

Gilbertson, Timothy A., Lidong Liu, David A. York, & George A. Bray. (1998). Dietary Fat Preferences Are Inversely Correlated with Peripheral Gustatory Fatty Acid Sensitivity^a. Annals of the New York Academy of Sciences. 855(1). 165–168. 85 indexed citations

11.

Lin, Xi, Mark Chavez, Richard C. Bruch, et al.. (1998). The Effects of a High Fat Diet on Leptin mRNA, Serum Leptin and the Response to Leptin Are Not Altered in a Rat Strain Susceptible to High Fat Diet-Induced Obesity. Journal of Nutrition. 128(10). 1606–1613. 62 indexed citations

12.

Smith, Brenda, David A. York, & George A. Bray. (1998). Chronic d-Fenfluramine Treatment Reduces Fat Intake Independent of Macronutrient Preference. Pharmacology Biochemistry and Behavior. 60(1). 105–114. 31 indexed citations

13.

Kilroy, Gail, et al.. (1996). Abnormal Regulation of Hepatic Glucocorticoid Receptor mRNA and Receptor Protein Distribution in the Obese Zucker Rat. Obesity Research. 4(2). 133–143. 18 indexed citations

14.

Nagase, Hiromi, George A. Bray, & David A. York. (1996). Effects of pyruvate and lactate on food intake in rat strains sensitive and resistant to dietary obesity. Physiology & Behavior. 59(3). 555–560. 35 indexed citations

15.

Lin, Ling, David A. York, & George A. Bray. (1996). Comparison of Osborne‐Mendel and S5B/PL Strains of Rat: Central Effects of Galanin, NPY, β‐Casomorphin and CRH on Intake of High‐Fat and Low‐Fat Diets. Obesity Research. 4(2). 117–124. 43 indexed citations

16.

Lin, Lih‐Yuan, et al.. (1995). Differential effects of enterostatin, galanin and opioids on high-fat diet consumption. Brain Research. 702(1-2). 55–60. 49 indexed citations

17.

Nagase, Hajime, et al.. (1994). Vagal‐Central Nervous System Interactions Modulate the Feeding Response to Peripheral Enterostatin. Obesity Research. 2(6). 527–534. 31 indexed citations

18.

Okada, Shuichi, David A. York, George A. Bray, & Charlotte Erlanson‐Albertsson. (1991). Enterostatin (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase, selectively reduces fat intake. Physiology & Behavior. 49(6). 1185–1189. 103 indexed citations

19.

Holt, S. J. & David A. York. (1989). Interaction of intracerebroventricular insulin and glucose in the regulation of the activity of sympathetic efferent nerves to brown adipose tissue in lean and obese Zucker rats. Brain Research. 500(1-2). 384–388. 19 indexed citations

20.

Holt, S. J. & David A. York. (1988). Effect of lateral hypothalamic lesion on brown adipose tissue of zucker lean and obese rats. Physiology & Behavior. 43(3). 293–299. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact